Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Benchmarks of meaningful impairment on the MSFC and BICAMS.
Temporal Hierarchical Adaptive Texture CRF for Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI.
Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists.
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitis.
Efferent manifestations of multiple sclerosis.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Prognostic factors of acute partial transverse myelitis-reply.
Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
Disease modifying and antiangiogenic activity of 2-methoxyestradiol in a murine model of rheumatoid arthritis.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Bilateral optic neuritis after inactivated influenza vaccination.
Brain abnormalities in neuromyelitis optica spectrum disorder.
Central nervous system lymphoma initially diagnosed as tumefactive multiple sclerosis after brain biopsy.
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain.
Exposure to anaesthetic agents does not affect multiple sclerosis risk.
Steps Per Day Among Persons With Multiple Sclerosis: Variation by Demographic, Clinical, and Device Characteristics.
Cost-effectiveness of injectable disease-modifying therapies for the treatment of relapsing forms of multiple sclerosis in Spain.
Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis.
Natalizumab therapy for multiple sclerosis.
Spinal Cord Normalization in Multiple Sclerosis.
Disability in multiple sclerosis: When synaptic long-term potentiation fails.

Pages